Videos

Updates from SightLife Surgical - 2017

Updates from SightLife Surgical

By Mario Admin | May 11, 2017

Monty Montoya, President & CEO, delivered many updates on the company’s new take on corneal care to OIS@ASCRS. The start-up is evaluating tissue, preparing tissue…

Read More
SightGlass Vision, a New Company to OIS 2017

SightGlass Vision, a New Company to OIS

By Mario Admin | May 11, 2017

Thomas Chalberg, founder and CEO, introduced a new company to OIS, SightGlass Vision, which he said hopes to revolutionize myopia care. Myopia is skyrocketing, with…

Read More
Update on ReVision Optics' Raindrop Inlay for Presbyopia - 2017

Update on ReVision Optics’ Raindrop Inlay for Presbyopia

By Mario Admin | May 11, 2017

Sarah Cannon, Director of Global Marketing, updated OIS@ASCRS on the commercial launch of its Raindrop inlay for presbyopia. “We are going to be scaling up…

Read More
Progress of Refocus Group's Clinical Trial - 2017

Progress of Refocus Group’s Clinical Trial

By Mario Admin | May 11, 2017

Mike Judy, CEO, Refocus Group, a company dedicated to non-invasive surgical solutions for presbyopia, presented early data on the its ongoing clinical trial. The firm…

Read More
Presbyopia Therapies

Progress of Presbyopia Therapies’ LiquidVision

By Mario Admin | May 11, 2017

Jim McCollum, Co-founder & Board member, introduced LiquidVision, an eye drop regimen that might correct presbyopia. The drops would be administered daily, or as needed,…

Read More
Gerd Auffarth's Perspective on Presbia’s Flexivue Microlens - 2017

Gerd Auffarth’s Perspective on Presbia’s Flexivue Microlens

By Mario Admin | May 11, 2017

Board member Gerd Auffarth, MD, shared his unique perspective on Presbia’s Flexivue Microlens designed to eliminate the need for reading glasses.

Read More
Progress of PowerVision's FluidVision - 2017

Progress of PowerVision’s FluidVision

By Mario Admin | May 11, 2017

Barry Cheskin, Co-founder, President, & CEO, delivered early results on the release of FluidVision 2020 into the clinic. The company reports 24 successful surgeries to…

Read More
Omega Opthalmics’ First Public Implantation of Its Omega Gemini Refractive Capsule 2017

Omega Ophthalmics’ First Public Implantation of Its Omega Gemini Refractive Capsule

By Mario Admin | May 11, 2017

Gary Wörtz, MD, chief medical officer of Omega Ophthalmics, allowed OIS attendees to see the first public implantation of his company’s Omega Gemini Refractive Capsule.…

Read More
Clinical progress of Ocular Therapeutix's Dextenza 2017

Clinical Progress of Ocular Therapeutix’s Dextenza

By Mario Admin | May 11, 2017

Jonathan Talamo, MD, chief medical officer at Ocular Therapeutix updated OIS@ASCRS attendees on the clinical progress of Dextenza, which is the subject of an NDA…

Read More
Progress of Mynosys Cellular Devices' Zepto 2017

Progress of Mynosys Cellular Devices’ Zepto

By Mario Admin | May 11, 2017

John Hendrick, president and CEO of Mynosys Cellular Devices, reported strong progress for Zepto, a disposable capsulotomy device. The company completed US clinical trials and…

Read More
Clinical Progress of Mati Therapeutics' Nepafenac 2017

Clinical Progress of Mati Therapeutics’ Nepafenac

By Mario Admin | May 11, 2017

Bob Butchofsky, CEO of Mati Therapeutics, updated OIS@ASCRS on the company’s punctal plug delivery system, introducing 12-week data from a Phase II multicenter clinical trial…

Read More
Diagnostic Capabilities of LacriScience's LacriPen 2017

Diagnostic Capabilities of LacriScience’s LacriPen

By Mario Admin | May 11, 2017

Chris Geddes, MD, chief biomedical/plasmonics consultant at LacriScience, previously introduced his company’s LacriPen as a method of measuring tear osmality. In this presentation, Dr. Geddes…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.